UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 249

Sortiert nach

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

BMC cancer, 2016-02, Vol.16 (168), p.168-168, Article 168

2016

Volltextzugriff (PDF)

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

British journal of cancer, 2011-09, Vol.105 (6), p.847-853

2011

Volltextzugriff (PDF)

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor

Annals of oncology, 2018-02, Vol.29 (2), p.514-515

2018

Volltextzugriff (PDF)

Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-03, Vol.35 (3), p.e245-e255

2023

Volltextzugriff (PDF)

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC

Annals of oncology, 2019-04, Vol.30, p.ii79-ii80

2019

Volltextzugriff (PDF)

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

Cancer radiothérapie, 2022-09, Vol.26 (5), p.670-677

2022

Volltextzugriff (PDF)

Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)

Annals of oncology, 2018-10, Vol.29, p.viii508-viii509

2018

Volltextzugriff (PDF)

Management of a progressing prostate cancer: results of a national study

Progrès en urologie (Paris), 2017-05, Vol.27 (6), p.381-388

2017

Volltextzugriff (PDF)

2541 Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting

European journal of cancer (1990), 2015-09, Vol.51, p.S489-S489

2015

Volltextzugriff (PDF)

2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel

European journal of cancer (1990), 2015-09, Vol.51, p.S488-S488

2015

Volltextzugriff (PDF)

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

The New England journal of medicine, 2018-06, Vol.378 (24), p.2288-2301

2018

Volltextzugriff (PDF)

Neuroendocrine carcinoma of the digestive tract: a literature review

La revue de medecine interne, 2013-11, Vol.34 (11), p.700-705

2013

Volltextzugriff (PDF)

Targeting KRAS pathway in NSCLC therapy

Bulletin du cancer, 2009-12, Vol.96 Suppl, p.S69

2009

Volltextzugriff (PDF)

Fever and cancer: components of diagnosis for optimal management

La revue de medecine interne, 2013-09, Vol.34 (9), p.545-552

2013

Volltextzugriff (PDF)

7051 POSTER Bicalutamide in Combination With Vandetanib or Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease Progression – a Randomized, Double-blind Phase II Trial

European journal of cancer (1990), 2011, Vol.47, p.S500-S500

2011

Volltextzugriff (PDF)

Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

European urology, 2023-02, Vol.83, p.S1974

2023

Volltextzugriff (PDF)

V070 - Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

European urology, 2023-02, Vol.83, p.S1974-S1974

2023

Volltextzugriff (PDF)

1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)

Annals of oncology, 2022-09, Vol.33, p.S1341-S1342

2022

Volltextzugriff (PDF)

Cancer chemotherapy of the upper aerodigestive tract

Cancer radiothérapie, 2008-03, Vol.12 (2), p.110-119

2008

Volltextzugriff (PDF)

IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis

Annals of oncology, 2017-09, Vol.28, p.v417-v417

2017

Volltextzugriff (PDF)

MA25.03 Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S351-S352

2019

Volltextzugriff (PDF)

Fièvre et cancer : éléments de diagnostic pour une prise en charge adaptée

La revue de medecine interne, 2013-09, Vol.34 (9), p.545-552

2013

Volltextzugriff (PDF)

Abituzumab (Di17E6, Emd 525797) Treatment for Chemotherapy-Naive Patients with Asymptomatic or Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (Mcrpc): Primary Outcomes of the Placebo-Controlled Phase 2 Study Perseus (Nct01360840)

Annals of oncology, 2014-09, Vol.25, p.iv266

2014

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(224)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(83)
Humans
(68)
Life Sciences & Biomedicine
(68)
Oncology
(49)
Male
(40)
Middle Aged
(30)
Aged
(28)
Female
(22)
Adult
(19)
Aged, 80 And Over
(19)
Lung Neoplasms - Drug Therapy
(18)
Sciences Biologiques Et Medicales
(15)
Sciences Medicales
(15)
Technology
(15)
Antineoplastic Agents - Therapeutic Use
(14)
Prostate Cancer
(14)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(13)
Materials Science
(12)
Retrospective Studies
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor

Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)

Management of a progressing prostate cancer: results of a national study

2541 Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting

2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

Neuroendocrine carcinoma of the digestive tract: a literature review

Targeting KRAS pathway in NSCLC therapy

Fever and cancer: components of diagnosis for optimal management

7051 POSTER Bicalutamide in Combination With Vandetanib or Placebo in Patients With Castration-refractory Metastatic Prostate Cancer Without Any Clinical Symptom Related to Disease Progression – a Randomized, Double-blind Phase II Trial

Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial

Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

V070 - Robot-assisted retroperitoneal lymph node dissection and vena cava thrombectomy for residual masses of germ cell tumor

1757P Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC)

Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial

Cancer chemotherapy of the upper aerodigestive tract

IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis

MA25.03 Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients

Fièvre et cancer : éléments de diagnostic pour une prise en charge adaptée

Abituzumab (Di17E6, Emd 525797) Treatment for Chemotherapy-Naive Patients with Asymptomatic or Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (Mcrpc): Primary Outcomes of the Placebo-Controlled Phase 2 Study Perseus (Nct01360840)

Suchergebnisse filtern